Varian Medical Systems, Inc.  

(Public, NYSE:VAR)   Watch this stock  
Find more results for VAR
-1.04 (-1.10%)
Mar 6 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 93.00 - 94.12
52 week 76.73 - 95.70
Open 93.52
Vol / Avg. 777,018.00/841,516.00
Mkt cap 9.44B
P/E 24.24
Div/yield     -
EPS 3.84
Shares 100.07M
Beta 0.88
Inst. own 96%
Apr 29, 2015
Q2 2015 Varian Medical Systems Inc Earnings Release - 4:00PM EDT - Add to calendar
Feb 12, 2015
Varian Medical Systems Inc Annual Shareholders Meeting
Jan 28, 2015
Q1 2015 Varian Medical Systems Inc Earnings Call
Jan 28, 2015
Q1 2015 Varian Medical Systems Inc Earnings Release
Jan 13, 2015
Varian Medical Systems Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '15) 2014
Net profit margin 12.65% 13.24%
Operating margin 17.54% 18.73%
EBITD margin - 21.15%
Return on average assets 11.08% 11.83%
Return on average equity 23.16% 24.24%
Employees 6,800 -
CDP Score - 89 C


3100 Hansen Way
PALO ALTO, CA 94304-1030
United States - Map
+1-650-4245834 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Company�s products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Company�s customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors� offices and cancer care clinics.

Officers and directors

R. Andrew Eckert Independent Chairman of the Board
Age: 52
Bio & Compensation  - Reuters
Dow R. Wilson President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Elisha W. Finney Chief Financial Officer, Corporate Executive Vice President - Finance
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Clarence R. Verhoef Senior Vice President - Finance, Corporate Controller
Age: 58
Bio & Compensation  - Reuters
John W. Kuo Senior Vice President, General Counsel, Corporate Secretary
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kolleen T. Kennedy Senior Vice President, President - Oncology Systems
Age: 54
Bio & Compensation  - Reuters
Sunny Sanyal Senior Vice President; President, Imaging Components Businesses
Age: 49
Bio & Compensation  - Reuters
Timothy E. Guertin Non-Executive Vice Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Susan L. Bostrom Independent Director
Age: 53
Bio & Compensation  - Reuters
Regina E. Dugan Ph.D. Independent Director
Age: 51
Bio & Compensation  - Reuters